What is BofA Securities's price target for USPH?

BofA Securities's latest stated price target for U.S. Physical Therapy Inc. (USPH) is $115, from its action on Dec 16, 2024.

What is BofA Securities's rating on USPH?

BofA Securities rates USPH Buy, a bullish rating, as of Dec 16, 2024.

When did BofA Securities last change its view on USPH?

On Dec 16, 2024, BofA Securities upgrades to Buy from Neutral, price target $100 to $115.

Analyst firms · BofA Securities · USPH

BofA Securities USPH price target and rating history

U.S. Physical Therapy Inc. (USPH) · Health Care

BofA Securities rates U.S. Physical Therapy Inc. (USPH) Buy with a $115 price target, as of its latest action on Dec 16, 2024. It has published 3 rating actions on USPH since June 2023, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $115
Median target, all firms: Too few
Actions on USPH: 3

BofA Securities price target on USPH

BofA Securities price target on USPH, each point a stated target, June 2023 to December 2024.

Every BofA Securities rating on USPH

Dec 16, 2024
UpgradeBofA Securities upgrades to Buy from Neutral, price target $100 to $115
Oct 7, 2024
DowngradeBofA Securities downgrades to Neutral from Buy, price target $114 to $90
Jun 30, 2023
InitiateBofA Securities starts coverage at Buy, price target $138

How other firms rate USPH

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
Barrington Research	Outperform	$90	May 13, 2026
Jefferies	Buy	$102	Mar 10, 2026

Questions about BofA Securities and USPH

What is BofA Securities's price target for USPH?: BofA Securities's latest stated price target for U.S. Physical Therapy Inc. (USPH) is $115, from its action on Dec 16, 2024.
What is BofA Securities's rating on USPH?: BofA Securities rates USPH Buy, a bullish rating, as of Dec 16, 2024.
When did BofA Securities last change its view on USPH?: On Dec 16, 2024, BofA Securities upgrades to Buy from Neutral, price target $100 to $115.

All BofA Securities ratings USPH news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.